About This Fund
Hiroshima Venture Capital is a stage agnostic venture capital firm investing in Japan. The firm focuses on technology start-ups engaged in the areas such as FinTech and also in life science start-ups such as BioTech, BioScience. Notable portfolio companies include Moneytree, Tech bureau Lab, Chiome Biosciences, PhoenixBio.
Investment Focus
Sectors
Stages
Check Size
$3M-$10M
Geography
What They Look For
Japan-based (Hiroshima/regional focus), high-growth potential targeting IPO, new technologies/business models, university spinouts, 6-10 year old companies, mid-sized/SMEs/ventures
Preparing to pitch Hiroshima Venture Capital?
CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.
Analyze My Deck →